These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 39294523)

  • 1. Stage IV gastric cancer with microsatellite instability-high achieving long-term survival by gastrectomy after nivolumab as third-line therapy: a case report and literature review.
    Kumagai H; Baba S; Nikai H; Fujisawa R; Shimooki M; Sasaki A
    Surg Case Rep; 2024 Sep; 10(1):221. PubMed ID: 39294523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conversion surgery for stage IV gastric cancer with a complete pathological response to nivolumab: a case report.
    Matsumoto R; Arigami T; Matsushita D; Okubo K; Tanaka T; Yanagita S; Sasaki K; Noda M; Kita Y; Mori S; Kurahara H; Ohtsuka T
    World J Surg Oncol; 2020 Jul; 18(1):179. PubMed ID: 32693806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion surgery for microsatellite instability-high gastric cancer with a complete pathological response to pembrolizumab: a case report.
    Hidaka Y; Arigami T; Osako Y; Desaki R; Hamanoue M; Takao S; Kirishima M; Ohtsuka T
    World J Surg Oncol; 2022 Jun; 20(1):193. PubMed ID: 35689267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful Conversion Surgery for Stage IV Gastric Cancer after Nivolumab Monotherapy as Third-Line Chemotherapy.
    Watanabe H; Fujikawa H; Komori K; Kano K; Takahashi K; Yamada T; Inokuchi Y; Machida N; Yokose T; Rino Y; Masuda M; Ogata T; Oshima T
    Case Rep Gastroenterol; 2021; 15(2):562-567. PubMed ID: 34616257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Confirmed complete response to nivolumab for advanced gastric cancer with peritoneal dissemination: a case report.
    Takami T; Yasuda K; Uozumi N; Musiake Y; Shintani H; Kataoka N; Yamaguchi T; Makimoto S
    J Med Case Rep; 2021 Dec; 15(1):604. PubMed ID: 34930435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-Term Survival of an Adolescent and Young Adult Patient with Unresectable Advanced Gastric Cancer in Whom Multidisciplinary Treatment Was Effective].
    Namikawa T; Utsunomiya M; Yokota K; Kawanishi Y; Yamaguchi S; Munekage M; Maeda H; Kitagawa H; Nagata Y; Kobayashi M; Hanazaki K; Seo S
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1985-1987. PubMed ID: 38303273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A Case of Recurrent Gastric Cancer with Long-Term Control via Two Resections and Multidisciplinary Treatment Including Nivolumab].
    Bungo M; Takeno A; Hirao M; Hamakawa T; Yamamoto M; Matsui Y; Tokuyama S; Toshiyama R; Kawai K; Takahashi Y; Sakai K; Doi T; Goto K; Kato T; Takami K
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1715-1717. PubMed ID: 38303183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-Term Survival of a Patient with Advanced Antral Gastric Cancer Successfully Treated with Multidisciplinary Therapy].
    Hirao T; Yamamoto K; Oka Y; Takada N; Murao S; Higashiguchi M; Takeda T; Noguchi K; Danno K; Toyoda Y; Nakane S; Yamamoto H
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1560-1562. PubMed ID: 38303341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion surgery of Stage IV gastric cancer with peritoneal dissemination after nivolumab.
    Toyota Y; Okamoto K; Tanaka N; Colvin HS; Takahashi Y; Inaba T
    Int Cancer Conf J; 2021 Oct; 10(4):280-284. PubMed ID: 34567938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term survival achieved by repeated administration of ramucirumab after drug holidays due to proteinuria in recurrent gastric cancer.
    Uehata N; Kouzu K; Tsujimoto H; Sugasawa H; Wakamatsu K; Kishi Y; Ueno H
    Surg Case Rep; 2021 Apr; 7(1):97. PubMed ID: 33876326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A Case of Advanced Gastric Cancer in Which Tumor Relapse Was Observed after Discontinuation of Nivolumab Due to Complete Response, and for Which Re-Administration Was Initiated].
    Nishida K; Yagi H; Mizumoto R; Haeno M; Mori S; Nomura M; Yasuyama A; Yoshikawa Y; Sueda T; Matsumura T; Koga C; Miyagaki H; Tei M; Tsujie M; Akamaru Y
    Gan To Kagaku Ryoho; 2023 Mar; 50(3):343-345. PubMed ID: 36927904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A Case of Conversion Surgery after Nivolumab Monotherapy as Third-Line Therapy for Advanced Gastric Cancer].
    Nishitani A; Noma T; Sakata K; Ikeda K; Miyazaki S
    Gan To Kagaku Ryoho; 2023 Nov; 50(11):1199-1202. PubMed ID: 38056874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A Case of Curative Resection of the Local Advanced Gastric Cancer after SOX plus Nivolumab Chemotherapy, and the Pathological Diagnosis Was Complete Response].
    Harada K; Fukunaga K; Kashimoto K; Yamaguchi A
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1712-1714. PubMed ID: 38303182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion surgery after successful response to chemotherapy (S-1 + oxaliplatin + nivolumab) in a patient with stage IV gastric cancer with peritoneal metastasis (P1, CY1): a case report.
    Noma T; Nishi M; Takasu C; Wada Y; Yoshikawa K; Tokunaga T; Nakao T; Kashihara H; Yoshimoto T; Miyakami Y; Atsumi K; Uehara H; Shimada M
    Int Cancer Conf J; 2024 Jan; 13(1):11-16. PubMed ID: 38187176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A Case Report of P0CY1 Gastric Cancer Achieved Long-Term Survival after Treated with Ramucirumab Monotherapy].
    Udagawa M; Adikrisna R; Yamasaki Y; Ito A; Kobayashi K; Enjoji M; Kirimura S
    Gan To Kagaku Ryoho; 2020 Dec; 47(13):2068-2070. PubMed ID: 33468803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent gastric cancer sustaining a partial response after the nivolumab discontinuation because of immune-related adverse events: a case report.
    Arigami T; Matsushita D; Okubo K; Tanaka T; Sasaki K; Noda M; Kita Y; Mori S; Tsuruda Y; Kurahara H; Ohtsuka T
    Surg Case Rep; 2020 Oct; 6(1):271. PubMed ID: 33074364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful R0 resection after chemotherapy, including nivolumab, for gastric cancer with liver metastases: three case reports.
    Kawai J; Yasufuku I; Fukada M; Asai R; Sato Y; Tajima YJ; Saigo C; Kiyama S; Makiyama A; Tanaka Y; Okumura N; Murase K; Miyazaki T; Matsuhashi N
    Surg Case Rep; 2024 Jun; 10(1):138. PubMed ID: 38837046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion surgery for gastric remnant cancer with liver metastasis after nivolumab combination chemotherapy achieving pathological complete response: a case report and literature review.
    Katsumata K; Morimoto Y; Aoyama J; Yamada T; Katsuki Y; Nishiyama R; Egawa T
    Surg Case Rep; 2024 May; 10(1):107. PubMed ID: 38691201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful management of multiple liver metastasis from gastric cancer with second conversion surgery: A case report.
    Sato S; Tanabe K; Ota H; Saeki Y; Ohdan H
    Int J Surg Case Rep; 2023 Jun; 107():108340. PubMed ID: 37216732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Brain Metastasis Arising from Gastric Cancer during Long-Term Treatment Using Nivolumab].
    Namikawa T; Marui A; Yokota K; Kawanishi Y; Munekage M; Uemura S; Maeda H; Kitagawa H; Nagata Y; Kobayashi M; Hanazaki K
    Gan To Kagaku Ryoho; 2022 Dec; 49(13):1544-1546. PubMed ID: 36733129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.